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*Acanthamoeba,* 484--485

*Achromobacter,* MALDI-TOF mass spectrometry for, 572

*Actinomyces,* MALDI-TOF mass spectrometry for, 574

Adenoviruses, 448--449, 451, 453, 528, 534--536

Adrenomedullin, in sepsis, 417, 420

*Aeromonas,* 528, 535

Affirm VPIII assay, 473, 489

African trypanosomiasis, 467--468

Aichi virus, 534

Alere Determine TB-LAM Ag lateral flow test, 559

Algorithms, clustering, in MALDI-TOF mass spectrometry, 620--622

Amebiasis, 485--488

American trypanosomiasis (Chagas disease), 476--477

Amoeba, free-living, 470, 484--485

Amplicor *Mycobacterium tuberculosis* test, 554

Amplified *Mycobacterium tuberculosis* Direct Test, 554

AmpliVue *C difficile* test, 530--531, 534

Anaerobic bacteria

 in blood cultures, 652

 MALDI-TOF mass spectrometry for, 574

*Ancylostoma,* 487--488

Antibiotic Resistance Genes Database, 644

Antigen85, in tuberculosis, 561

Antigen-detection tests, for respiratory viruses, 440

Antimicrobial resistance

 in blood culture pathogens, 665--667

 MALDI-TOF mass spectrometry for, 602, 623

Antimicrobial susceptibility testing, 415, 695

Aptamers, in tuberculosis, 560--561

Aptima *Trichomonas vaginalis* assay, 473, 489

Arabinitol, in fungal infections, 540--541

*Ascaris lumbricoides,* 486--488

Aspergillosis

 biomarkers in, 506--511

 molecular diagnosis of, 512--519

*Aspergillus,* MALDI-TOF mass spectrometry for, 575--597, 616

*Aspergillus* Real-Time PCR Panel, 512--514, 516

Astroviruses, 528, 534--535

*Auroeobasidium/Hormonema,* MALDI-TOF mass spectrometry for, 576

Automation, **567--588**

 business case for, 584--587

 digital imaging in, 579--582

 history of, 706--707

 importance of, 567--569

 liquid microbiology and, 569--571

 of blood culture microorganism detection, 651--652, 664--665

 of polymicrobial blood culture identification, 614--615

 preanalytical, 571--578

 total laboratory, 582--584
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Babesiosis, 446, 475--476

BACcel, for blood cultures, 671, 673

*Bacillus,* MALDI-TOF mass spectrometry for, 574

BacT FX system, for blood cultures, 652

BacT/ALERT system, for blood cultures, 652, 664--665

BACTEC Lytic/10 bottles, for blood cultures, 665

BACTEC Plus, for blood cultures, 665

BACTEC/ALERT, for blood cultures, 671--672

Bacteremia, sepsis in. *See* Sepsis.

Bacteria, MALDI-TOF mass spectrometry for, 572--595

Bacterial strain typing. *See* Strain typing.

Bacteriophages, in Keypath MRSA/MSSA Blood Culture Test, 668

*Bacteroides fragilis,* MALDI-TOF mass spectrometry for, 603, 623

*Balmuthia mandrillaris,* 484--485

BD Max System, 655--656

BDG Fungitell assay, 509--510

Beta-lactamase, *Mycobacterium tuberculosis,* 561

Bile solubility test, for blood cultures, 664, 673

Binary typing, 633, 643--645

BinaxNOW *Staphylococcus aureus* assay, for blood cultures, 668, 673

BioFire assays, for respiratory viruses, 451--453

Bioinformatics, 645

Biomarkers

 for fungal infections, 506--511, 519

 for gastroenteritis, 543

 for *Mycobacterium tuberculosis,* 558--562

 for sepsis, 415--422

bioMérieux VITEX 2ID, 671--672, 709

bioMérieux VITEX MS

 description of, 590--592, 612

 for bacteria identification, 592--595

 for blood cultures, 671--672

 for fungi identification, 595--597

Biosensors, for gastroenteritis, 541--543

*Blastocystis hominis,* 487

*Blastomyces dermatitidis,* 509

Blood cultures

 contamination of, 652

 microorganism detection in, **651--684**

* Candida,* 665--666, 669--671

* Enterococcus,* 656--658, 669--670

* Escherichia coli,* 658, 669--670

* Exoserohilum rostratum,* 519

 false-negative results of, 652

 fungi, 505--506, 615--617, 657--661

 Gram-negative bacteria, 657--661

 Gram-positive bacteria, 615, 657--661

 history of, 651--653

 in sepsis, 414--415, 422--423, 426, 428

* Klebsiella,* 669--670

* Listeria,* 656

 MALDI-TOF mass spectrometry for, 601, 613--617

 nanotechnology for, 656--657

 nucleic acid amplification tests for, 653--662

 polymicrobial, 614--615

* Pseudomonas aeruginosa,* 669--670

 pyrosequencing, 659

 rapid, 707

 specimen processing for, 613--614

* Staphylococcus,* 653--656

* Staphylococcus aureus,* 665, 668, 674

* Streptococcus,* 659, 672

* Streptococcus pneumoniae,* 664, 671

 subculture of, 652

Bloodstream infections. *See also* Blood cultures.

 MALDI-TOF mass spectrometry for, 613--617

 sepsis in. *See* Sepsis.

Bocaviruses, 535

*Bordetella pertussis,* 540

Bovine herpes virus, 544

Bovine respiratory syncytial virus, 544

Bovine viral diarrhea virus, 541

Breath, tuberculosis biomarkers in, 559--560

Bronchoalveolar fluid analysis, in fungal infections, 506--508

*Brugia malayi,* 468, 479--480

Bruker MALDI BioTyper, 612

 description of, 590--592

 for bacteria identification, 592--595

 for blood cultures, 671--672

 for fungi identification, 595--597

*Burkholderia*

 MALDI-TOF mass spectrometry for, 574

 strain typing of, 642
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*CALC-1* gene, in sepsis, 418

*Campylobacter,* 536, 539

*Campylobacter coli,* 535

*Campylobacter jejuni,* 528, 534--535, 541

*Candida*

 biomarkers in, 506--511

 in blood cultures, 665--667, 669--673

 MALDI-TOF mass spectrometry for, 575--597, 614--617

 molecular diagnosis of, 511--528

*Candida albicans* germ tube antibody assay, 509

*Candida* Real-Time PCR Panel, 512--513, 515--516

Capillary gel electrophoresis, for strain typing, 636, 638

Capillary Sanger sequencing, for strain typing, 639

Capillary sequence platforms, for strain typing, 636, 638

Carbapenamases, MALDI-TOF mass spectrometry for, 602

Card agglutination test, for African trypanosomiasis, 478

Cell culture, for respiratory viruses, 440

Cell lysis, for blood cultures, 613--614

Cell-analysis, real-time, for gastroenteritis, 545--546

Centrifugation, of urine specimens, for MALDI-TOF mass spectrometry, 617--618

Cepheid assays, for respiratory viruses, 443--445

Cestodes, 487--488

*cfiA* gene, *Bacteroides fragilis,* 623

Chagas disease, 466, 476--477

Chemical protein extraction, for blood cultures, 613--614

Chemiluminescence assay, for sepsis, 417, 421

Chemiluminescence sandwich immunoassay, for procalcitonin, 418

*Chlamydophila,* strain typing of, 639

Cholera toxin, 542

CHROMagar Candida, for blood cultures, 665--667

CHROMagar MRSA, for blood cultures, 667

Chromogenic agar, for blood cultures, 665--667, 673

Ciphergen Protein-Chip System, for African trypanosomiasis, 479

ClinProTools, 619

Clonality, MALDI-TOF mass spectrometry for, 622

*Clonorchis sinensis,* 488

*Clostridium,* strain typing of, 635

*Clostridium difficile,* 528, 530--534--536, 545--546, 721

 MALDI-TOF mass spectrometry for, 622

 typing of, 632, 636--637

*Clostridium perfringens,* 535, 546

Clustered, regularly interspersed short palindromic repeats (CRISPRs), for strain typing, 632

Clustering algorithms, in MALDI-TOF mass spectrometry, 620--622

Coinfections, of respiratory viruses, 455

CompassXport tool, 618--619

Compensatory antiinflammatory response syndrome, 415

Comprehensive Antibiotic Resistance Database, 644

Computers, in sequencing, 694

Conductometric biosensors, for gastroenteritis, 542

Confusion matrix, in MALDI-TOF mass spectrometry, 620--621

Consensus multilocus sequence typing, 632, 639--640

Coronaviruses, molecular diagnosis of, 451, 454

*Corynebacterium,* MALDI-TOF mass spectrometry for, 574

C-reactive protein

 in gastroenteritis, 543

 in sepsis, 416--418

CRISPRs (clustered, regularly interspersed short palindromic repeats), for strain typing, 632

Crohn disease, 543

*Cronobacter,* strain typing of, 635

*Cryptococcus,* MALDI-TOF mass spectrometry for, 575--576

Cryptosporidiosis, 471, 485--488, 536, 544

Culture-independent diagnostic testing, 645--646

Cultures. *See also* Blood cultures.

 for free-living amoeba, 485

 for fungal infections, 505--506

 for gastroenteritis, 528--529

 for leishmaniasis, 481

α-Cyano-4-hydroxycinnamic acid, in MALDI-TOF mass spectrometry, 612, 623

Cytokines

 in gastroenteritis, 543--544

 in sepsis, 417, 421
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Data storage, in sequencing, 691

Databases, for sequencing, 692

Decision support, 723

Definitions Biomarkers Working Group, 506

Determine TB-LAM Ag lateral flow test, 559

Diafiltration, of urine specimens, for MALDI-TOF mass spectrometry, 617--618

Diarrhea. *See also* Gastroenteritis.

 in parasitic disease, 470--472, 485--488

*Dientamoeba fragilis,* 471, 487

Differential centrifugation, for blood cultures, 613--614

Digital imaging, 579--582

Direct Amplification Disk, 446

Direct bile solubility test, for blood cultures, 664, 673

Direct tube coagulation test, for blood culture, 662

Disk diffusion susceptibility test, 708

Diversity, in sequencing, 690

DNase test, thermostable, for blood cultures, 664, 673
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Electrical impedance detection methods, for gastroenteritis, 545

Electrochemical impedimetric immunosensors, for gastroenteritis, 541--542

Electron microscopy, for gastroenteritis, 528--529

Electronic medical records, 722--723

Electrophoresis, pulsed field gel, for strain typing, 631--632, 634--636

Electrospray ionization mass spectrometry, 659--670

 for babesiosis, 476

*emm* gene, for strain typing, 632, 639

*Encephalitozoon,* 489--490

Endotoxin, in sepsis, 417, 421--422

Endotoxin activity assay, for sepsis, 417, 421

*Entamoeba gingivalis,* 486

*Entamoeba histolytica,* 536

*Entamoeba histolytica/dispar,* 470, 485--488

*Enterobacteriaceae,* MALDI-TOF mass spectrometry for, 601

*Enterococcus*

 in blood cultures, 656, 669--670

 strain typing of, 635

 vancomycin resistance and susceptibility in, MALDI-TOF mass spectrometry for, 601, 603, 622

*Enterocytozoon,* 489--490

Enteroviruses, 452, 454, 534

Enzyme immunoassay, for gastroenteritis, 528

Enzyme-linked immunosorbent assay

 for filariasis, 480

 for gastroenteritis, 543

 for tuberculosis, 561

 Hyplex BloodScreen assay with, 661--662

Epidemiology, MALDI-TOF mass spectrometry for, 622

Epstein-Barr virus, PCR for, 718--719

*Escherichia,* strain typing of, 635, 638

*Escherichia coli,* 528, 534--536, 541--542

 antibiotic resistance in, 602

 in blood cultures, 658, 669--670

 misidentification of, 612

 strain typing of, 643

eSensor Respiratory Viral Panel, 449

ESwab, 570

European *Aspergillus* PCR Initiative, 518

European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group, 508

*Exoserohilum rostratum,* 519
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Filariasis, 467--468

FilmArray Blood Culture Identification panel, 657--659, 662--663

FilmArray GI assay, 487

FilmArray Respiratory Panel, 451--453

Filter paper, of urine specimens, for MALDI-TOF mass spectrometry, 617--618

Fluconazole resistance, in blood cultures, 666

Flukes, 487--488

Fluorescence microscopy. *See* PNA FISH (peptide nucleic acid fluorescent in situ hybridization assay).

Fluorescent resonance energy transfer (FRET), for malaria, 463

Focus Diagnostic assays, for respiratory viruses, 445--446

Fontana Masson strain, for fungi, 519

Formalin-fixed paraffin-embedded tisues, fungi in, 519

Foundation for Innovative New Diagnostics, 479

Free-living amoebae, 484--485

*Fructobacillus,* MALDI-TOF mass spectrometry for, 622

Fungal infections, **505--525**

 biomarkers for, 506--511, 519

 MALDI-TOF mass spectrometry for, 615--617

 molecular diagnosis of, 511--518

Fungitell assay, 509--510

*Fusarium,* MALDI-TOF mass spectrometry for, 597, 616
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Galactomannan, in fungal infections, 506--509

Ganglioside-sensitized liposomes, for gastroenteritis, 542

Gastroenteritis, **528--552**

 biosensors for, 541--545

 genomic assays for, 529--540

 historical detection methods for, 527--529

 multiplex PCR for, 534--537, 721

 proteomics for, 529, 541--546

 real-time cell analysis systems for, 545--546

Gel-based separation, for blood cultures, 613--614

GeneOhm Cdiff Assay, 530--531

GeneOhm StaphSR assay, 655--656, 662--663

GeneXpert Flu Assay, 443--444

GeneXpert MRSA/SA blood culture assay, 653--664, 672--674, 709

GeneXpert Xpert MTV/RIF test, 556--558

GenMark assays, for respiratory viruses, 448--449

Genome analysis, for gastroenteritis, 539

Genomic assays, for gastroenteritis, 529--540

Genotype MTDR test, 555--556

GenoType Mycobacteria Direct test, 554

Giardiasis, 471, 485--488, 536

1,3-ß-[D-]{.smallcaps}Glucan, in fungal infections, 509--540

Glutamate dehydrogenase antigen test, for gastroenteritis, 528

Gold nanotechnology, for blood cultures, 656--657

G-protein\--coupled receptors, for gastroenteritis, 545

Gram-negative organisms, MALDI-TOF mass spectrometry for, 602, 715--717

Gram-positive bacteria, MALDI-TOF mass spectrometry for, 615
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HACEK organisms, MALDI-TOF mass spectrometry for, 597

Helicase method, for *Staphylococcus* detection, 654

*Helicobacter pylori,* 544

HeliScope System, for gastroenteritis, 539--540

Helminths, intestinal, 470--472, 485--488

High-resolution fragment analysis, for strain typing, 632, 636--638

*Histoplasma capsulatum,* in blood cultures, 652

Hologic assays, for respiratory viruses, 442--443

Human metapneumovirus, molecular diagnosis of, 442--443, 448, 451

Hyplex BloodScreen assay, 661--663

 for sepsis, 423, 427
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Illumigene *C difficile* Assay, 530--532

Immunochromatography

 for blood cultures, 668

 for filariasis, 480

Immunocytotoxicity assay, in gastroenteritis, 545

Immunoenzymatic microplate sandwich assay, for fungal infections, 506

Immunoglobulin, salivary, in gastroenteritis, 544

Immunoluminometric procalcitonin assay, for sepsis, 419

Immunoparalysis, in sepsis, 415

Immunosensors, for gastroenteritis, 541--543

Incidental findings, in sequencing, 694--695

Incubators, digital imaging in, 579--582

Infectious Diseases Society of America, fungal infection guidelines of, 508

Influenza virus, molecular diagnosis of, 443--453

INNO-LiPA TB test, 555

Innova plating instrument, 571--572, 574--575

InocuLAB, 573

InoquIA plating instrument, 571--572, 575--576

Interferons

 in gastroenteritis, 543--544

 in *Mycobacterium tuberculosis,* 559, 561

Interleukins

 in gastroenteritis, 543--544

 in sepsis, 417, 421

Intestinal parasites, 470--472, 485--488

Ion Proton System, for gastroenteritis, 540

IQuum assays, for respiratory viruses, 445

Isoplater, 571, 573
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Keypath MRSA/MSSA Blood Culture Test, 668

*Klebsiella,* in blood cultures, 669--670

K-mer based approaches, to strain typing, 632, 642
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Label-free detection methods, for gastroenteritis, 545

*Lactococcus,* MALDI-TOF mass spectrometry for, 622

LCx, *M tuberculosis* test, 554

LDMS, for malaria, 465

Leishmaniasis, 469, 481--482

Leishmanin skin test, 481--482

*Leuconostoc,* MALDI-TOF mass spectrometry for, 622

LIASON BRAHMS PCT-immunoluminometric assay, for procalcitonin, 419

Liat Influenza A/B assay, 445

Line probe assays, for *Mycobacterium tuberculosis,* 558

Lipoarabinomannan, in tuberculosis, 559

Lipopolysaccharide-binding protein, in sepsis, 417, 419--420

Liquid microbiology, 569--571

*Listeria*

 in blood cultures, 656

 MALDI-TOF mass spectrometry for, 574, 603

 strain typing of, 603, 639

Loa loa, 468, 479--480

Loop-mediated isothermal amplification

 for African trypanosomiasis, 467--468, 478--479

 for leishmaniasis, 469

 for malaria, 465, 474--475

 for *Mycobacterium tuberculosis,* 557--558

 for toxoplasmosis, 470, 484

Luminex assays

 for intestinal parasites, 486

 for respiratory viruses, 449--451

Luminex Multiplex PCR xMAP assay, for fungal infections, 512--513

Luminex xMAP technology, for gastroenteritis, 535

Lymphatic filariasis, 467--468

Lysis centrifugation, for blood cultures, 652
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Malaria, 462--465, 474--475, 540

MALDI Sepsityper kit, 601, 671--673

MALDIquant, 620

MALDI-TOF mass spectrometry, **589--609,** 709--717

 clinical utility of, 710--717

 commercial systems for, 590--592

 costs of, 598, 710

 dangers of, 711

 description of, 710

 disadvantages of, 711

 economics of, 710

 emerging uses of, **611--628**

 bloodstream infections, 613--617

 classification, 619--620

 clustering algorithms, 620--622

 limitations of, 612--613

 postanalytical, 618--622

 spectra refinements, 618--619

 urinary tract infections, 617--618

 for antimicrobial resistance detection, 602, 623

 for blood cultures, 673, 715--717

 for clonality studies, 622

 for epidemiologic information, 622

 for microbial identification

 advantages of, 597--598

 bacteria, 592--595

 direct, 601--602

 disadvantages of, 599--600

 fungi, 517, 595--597

 Gram-negative, 715--717

 principles of, 590--592

* Streptococcus,* 716

 for strain typing, 602--603, 622

 future applications of, 600--603

 history of, 589--599

 implementation of, 714

 patient benefits of, 714

 unusual organisms found in, 712--714

 work flow with, 710--711

Mannan, in fungal infections, 540--541

*Mansonella,* 479--480

Mass spectrometry

 for babesiosis, 476

 for malaria, 475

 matrix-assisted laser desorption ionization-time-of-flight. *See* MALDI-TOF mass spectrometry.

 PCR with, for blood cultures, 663

MassSpecWavelet, 620

MATLAB, 620

Matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF). *See* MALDI-TOF mass spectrometry.

MEDIC (Multicenter Endotoxin Detection in Critical Illness) trial, 417, 421

Medical education, for sequencing, 696

Medical laboratory technologists, 569

Meningitis outbreak of 2012, investigation of, 519

Meningococcus Genome Informatics Platform, 639

Metabolomics, for *Mycobacterium tuberculosis,* 561

Metagenomics, 689--690

Methicillin resistance, in *Staphylococcus aureus. See* MRSA (methicillin-resistant *Staphylococcus aureus*).

Microscopy

 for African trypanosomiasis, 478

 for filariasis, 480

 for free-living amoebae, 485

 for gastroenteritis, 528

 for intestinal helminths, 487--488

 for leishmaniasis, 481

 for microsporidia, 489

 for trichomoniasis, 488--489

Microsporidiosis, 473, 489--490

Minimum Information for Publication of Quantitative Real-Time PCR Experiments guidelines, 511

Mixed inflammatory response syndrome, 415

MLST (multilocus sequence typing), 632, 639--640

Molecular diagnosis, 717--722. *See also individual methods and infections.*

 for fungal infections, 511--518

 for *Mycobacterium tuberculosis,* 554--558

 for respiratory viruses, 441--455

 for sepsis, 422--429

 product selection for, 717--718

 quantitative testing in, 718

Molecular phylogeny, 687--689

MolYsis Basic kit, 601

*Moraxella,* MALDI-TOF mass spectrometry for, 621

MRSA (methicillin-resistant *Staphylococcus aureus*)

 antibiotic resistance in, MALDI-TOF mass spectrometry for, 602

 in blood cultures, 653--657, 663, 665--668, 674

 in sepsis, 422, 424--425

 MALDI-TOF mass spectrometry for, 602--603, 622

 strain typing of, 632, 638--640

MRSA ID, 667

*Mucorales,* MALDI-TOF mass spectrometry for, 597

Multicenter Endotoxin Detection in Critical Illness (MEDIC) trial, 417, 421

Multilocus sequence typing, 632, 639--640

Multiple locus VNTR analysis, for strain typing, 636, 638

Multiplex PCR, 719

 for African trypanosomiasis, 478--479

 for babesiosis, 476

 for blood cultures, 658

 for free-living amoebae, 485

 for gastroenteritis, 534--538, 721

 for intestinal parasites, 486--487

Multiplex protein/antigen liquid arrays, for gastroenteritis, 543--544

Multiplex xTAG Fungal ASR Luminex assay, 512, 514

MycAssay *Aspergillus,* 512, 515--516

*Mycobacterium*

 in blood cultures, 652

 MALDI-TOF mass spectrometry for, 574

 strain typing of, 635, 643

*Mycobacterium tuberculosis,* **553--566**

 biomarkers for, 558--562

 MALDI-TOF mass spectrometry for, 574

 molecular diagnosis of, 554--558

 multidrug-resistant, 555--556, 568

N {#sec13}
=

NAATs. *See* Nucleic acid amplification tests; *specific tests.*

*Naegleria fowleri,* 484--485

Nanosphere assays, for respiratory viruses, 446--448

Nanotechnology, for blood cultures, 656--657

National Institute of Allergy and Infectious Diseases Mycoses Study Group, 508--511

*Necator americanus,* 487--488

*Neisseria,* strain typing of, 639, 642

Nematodes, 487--488

NeutrAvidin, for gastroenteritis, 542

Next-generation sequencing-based microbiota determination, for gastroenteritis, 538--540

Nitrocellulose nanofibrous membrane, for gastroenteritis, 541

Nitrous oxide, in gastroenteritis, 543--544

*Nocardia,* MALDI-TOF mass spectrometry for, 574

Noninstrumented nucleic acid platform, for malaria, 465, 475

Norovirus, 528, 534--536

*Nosema,* 489--490

Nucleic acid amplification tests

 for African trypanosomiasis, 478--479

 for babesiosis, 475--476

 for blood cultures, 653--662

 for intestinal helminths, 487--488

 for malaria, 463--465, 474--475

 for microsporidia, 489--490

 for *Mycobacterium tuberculosis,* 554--558

 for respiratory viruses, 441--455

 for sepsis, 422--429

Nucleic acid lateral flow immunoassay (NALFIA), for malaria, 475

Nucleic acid sequencing. *See* Sequencing.

Nucleic acid-based sequenced -based amplification (NASBA)

 for African trypanosomiasis, 479

 for malaria, 474--475
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Oligochromatography, for African trypanosomiasis, 467, 479

Oligonucleotides, in tuberculosis, 560--561

*Onchcerca volvulus,* 479--480

Optoelectric immunosensors, for gastroenteritis, 542--543
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*Paecilomyces,* 513

Paraffin-embedded tissues, fungi in, 519

Paraflagellar rod protein A, in African trypanosomiasis, 478--479

Parainfluenza viruses, 448, 451, 453--454, 544

Parasitic diseases, **461--503**

 blood, 462--468, 474--480

 intestinal, 470--472, 485--488

 tissue, 469--470, 481--485

 urogenital, 483, 488--489

 versus microsporidia, 489--490

Parechoviruses, 534

PCR. *See* Polymerase chain reaction.

PCR-ribotyping, for strain typing, 632, 636--637

*Penicillium,* MALDI-TOF mass spectrometry for, 616

Pentraxin 3, in sepsis, 417, 421

Peptide nucleic acid fluorescent in situ hybridization assay. *See* PNA FISH (peptide nucleic acid fluorescent in situ hybridization assay).

Phenotypic methods, for blood cultures, 662, 664--672

Phoenix automated identification system, for blood cultures, 664--665

*Pichia,* MALDI-TOF mass spectrometry for, 576

*Plasmodium,* 540

Platelia kit, for fungal infections, 507--508

Platelia mannan antigen test, 510

Plating techniques, automation for, 569--582

PLEX-ID BAC Spectrum assay, 424, 428, 476

PLEX-ID Broad Fungal Assay, 512, 515--516

PNA FISH (peptide nucleic acid fluorescent in situ hybridization assay), 709

 for African trypanosomiasis, 467

 for blood cultures, 668--673

 for fungal infections, 514, 518

*Pneumocystis,* biomarkers in, 510

Polymerase chain reaction

 electrospray ionization mass spectrometry with, 659--670

 for African trypanosomiasis, 467--468, 478--479

 for babesiosis, 466, 475--476

 for blood culture microorganisms, 653--662

 for Chagas disease, 466, 476--477

 for cryptosporidiosis, 471

 for *Dientamoeba fragilis,* 471, 487

 for *Entamoeba histolytica/dispar,* 470

 for Epstein-Barr virus, 718--719

 for filariasis, 468, 480

 for free-living amoebae, 470, 485

 for fungal infections, 511--518

 for gastroenteritis, 534--538

 for giardiasis, 471

 for intestinal parasites, 473--474, 486--488

 for leishmaniasis, 469, 481--482

 for malaria, 465--466, 474--475

 for microsporidiosis, 474

 for *Mycobacterium tuberculosis,* 554--555

 for respiratory viruses, 441--455

 for schistosomiasis, 473

 for sepsis, 422--429

 for toxoplasmosis, 470, 482--484

Polymicrobial blood cultures, 614--615, 672

Portrait Toxigenic *C difficile* Assay, 530--531, 533

Postanalytical approach, MALDI-TOF mass spectrometry for, 618--622

Post-transplant lymphoproliferative disease, 718--719

Preanalytical automation, 571--578

PREVI Isola plating instrument, 571--572, 578

Principal-component analysis, in MALDI-TOF mass spectrometry, 620

Privacy issues, in sequencing, 694

Pro-adrenomedullin, in sepsis, 417, 420

ProbeTec Direct Test, for *Mycobacterium tuberculosis,* 554

Procalcitonin, in sepsis, 417--419

Prodesse kits, for respiratory viruses, 442--443

ProGastro CD assay, 530--532

Proteomics

 for gastroenteritis, 529, 541--546

 for *Mycobacterium tuberculosis,* 561

Provasopressin, in sepsis, 417, 420

Prove-it Sepsis assay, 423, 426--427, 661, 663

*Pseudomonas aeruginosa*

 in blood cultures, 669--670

 MALDI-TOF mass spectrometry for, 574

Pulsed field gel electrophoresis, for strain typing, 631--632, 634--636

PulseNet, 634--635, 638

PyroMark ID platform, for gastroenteritis, 539

Pyrosequencing

 for blood cultures, 659, 663

 for gastroenteritis, 538--539
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QuantiFERON-TB Gold Tube assay, 559

Quantitative testing, in molecular diagnosis, 718

QuickFISH, for blood cultures, 670--671, 673

Quidel assay, for respiratory viruses, 443
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=

Rapid antigen test, for gastroenteritis, 529

Rapid detection

 from blood cultures, **651--684**

 history of, 706--707

RapID NF O Plus, in MALDI-TOF mass spectrometry, 621

readBruker Flex Data tool, 618

Real-time cell-analysis, for gastroenteritis, 545--546

Recognition capability, in MALDI-TOF mass spectrometry, 620

RenDx Fungiplex panel, 516--517

Resistance, antimicrobial. *See* Antimicrobial resistance.

Respiratory syncytial virus, molecular diagnosis of, 441--443, 445--448

Respiratory viruses, **439--460**

 molecular diagnosis of, 719--720

 NAATS for, 441--455

Results, communication of, 722--723

Rhinoviruses, molecular diagnosis of, 442, 448, 452, 454

*Rhodotorula,* MALDI-TOF mass spectrometry for, 575

Ribospacer PCR, for strain typing, 632, 636--637

RNA FISH, for fungi, 519

Rotaviruses, 528, 534--536

Round worms, 487--488

rRNA genes, in pyrosequencing, 659

S {#sec18}
=

*Saccharomyces,* MALDI-TOF mass spectrometry for, 575

Salivary immunoglobulin, in gastroenteritis, 544

*Salmonella,* 528, 535--536, 544

 strain typing of, 603, 635, 638, 643

*Salmonella enterica,* 534

Sapovirus, 534--535

*Scedosporium,* 513, 519

Schistosomiasis, 473

Seeplex Diarrhea ACE Detection, 535

Seeplex Diarrhea Virus Panel, 535

SELDI-TOF, for African trypanosomiasis, 467

Selective reporting, 723

Sepsis, **413--437**

 agents causing, 652

 biomarkers for, 415--422

 clinical continuum of, 414--415

 incidence of, 414

 molecular diagnosis of, 422--429

SepsiTest

 for blood cultures, 662--663

 for sepsis, 424, 428

Sepsityper kit, 601, 613--614, 671

SeptiFast

 for blood cultures, 660--661, 663

 for fungal infections, 512, 515--516

 for sepsis, 424, 427--428

Sequencing, **685--704**

 clinical microbiology use of, 686--687

 computer limitations in, 693--694

 data interpretation in, 692--693

 data storage problems with, 691

 database quality and, 692

 diversity findings in, 690

 errors in, 692

 evolution of, 686

 for antimicrobial susceptibility, 695

 for strain typing, 638

 incidental findings in, 694--695

 integrating into clinical diagnostics, 691

 medical education for, 696

 metagenomics and, 689--690

 microbiome and, 695--696

 open nature of, 690

 privacy issues in, 694

 standards for, 691--692

 unexpected byproducts of, 687--689

Sequencing by Oligonucleotide Ligation and Detection (SOLiD), for gastroenteritis, 539

Serology

 for Chagas disease, 477

 for intestinal helminths, 487

 for leishmaniasis, 481

 for toxoplasmosis, 482--484

Shear horizontal surface acoustic wave device, for gastroenteritis, 542

*Shigella,* 534--536

 misidentification of, 612

 strain typing of, 635

Shock, septic. *See* Sepsis.

Simplexa assays, for respiratory viruses, 445--446

Simplexa *C difficile* Universal Direct Test, 530--533

Single number polymorphisms, in strain typing, 641--642

Single-molecule real-time sequencing, for gastroenteritis, 540

Smart Leish re-time PCR assay, 482

Solexa sequencing platform, for gastroenteritis, 539

SOLiD (Sequencing by Oligonucleotide Ligation and Detection), for gastroenteritis, 539

*Spa* gene, for strain typing, 632, 638--639

Specimen(s), MALDI-TOF mass spectrometry, 601--602, 613--614

Specimen collection, swab methods for, 569--571

Spectra MRSA, 667

Spectral preprocessing, in MALDI-TOF mass spectrometry, 620

*Spirometra erinacei,* 488

Sputum, tuberculosis biomarkers in, 560--561

Staph ID/R Blood Culture Panel, 654, 663

Staph SR assay, for sepsis, 422--425

StaphPlex assay, for sepsis, 423, 425

*Staphylococcus*

 in blood cultures, 653--656, 665, 668, 674

 strain typing of, 635

*Staphylococcus aureus,* 540

 classification of, 621

 in sepsis, 422, 424--425

 MALDI-TOF mass spectrometry for, 621

 methicillin-resistant. *See* MRSA (methicillin-resistant *Staphylococcus aureus*).

*Staphylococcus* M assay, for sepsis, 423, 425

Stool culture, for gastroenteritis, 528--529

Strain typing, **639--650**

 amplified fragment length polymorphism analysis for, 631, 634--636

 binary typing, 633, 643--645

 bioinformatics for, 645

 clustered, regularly interspersed short palindromic repeats for, 632

 culture independent testing and, 645--646

* emm* gene typing, 632, 639

 high-resolution fragment analysis, 632, 636--638

 importance of, 629--630

 k-mer based approaches, 632, 642

 MALDI-TOF mass spectrometry for, 602--603, 622

 methods selection for, 630--631

 multilocus sequence typing for, 632, 639--640

 pulsed field gel electrophoresis for, 631--632, 634--636

* spa* gene, 632, 638--639

 superMLST, 633, 643--645

 whole-genome sequencing for, 632, 640--642

Streptococcal antigen testing, for blood cultures, 664, 673

*Streptococcus*

 in blood cultures, 656

 MALDI-TOF mass spectrometry for, 572, 716

 misidentification of, 612

*Streptococcus pneumoniae*

 in blood cultures, 664, 671

 strain typing of, MALDI-TOF mass spectrometry for, 603

*Strongyloides stercoralis,* 487--488

SuperMLST, for strain typing, 633, 643--645

Supervised clustering, in MALDI-TOF mass spectrometry, 620--622

Support vector machine, for MALDI-TOF mass spectrometry, 619--620

Surface acoustic wave device, for gastroenteritis, 542

Surface second harmonic generation techniques, for gastroenteritis, 542--543

Swabs, for specimen collection, 569--571

Systemic inflammatory response syndrome. *See* Sepsis.

T {#sec19}
=

T2 Biosystems fungal assays, 517

*Taenia,* 488

Tapeworms, 487--488

TaqMan Array Card assay, for intestinal parasites, 486

Technology, in clinical practice, **705--729**. *See also specific instruments and techniques.*

Thermostable DNase test, for blood cultures, 664

Time-resolved amplified cryptate emission (TRACE) technology, for procalcitonin, 419

Total laboratory automation, 582--584

Toxoplasmosis, 470, 544

TRACE (Time-resolved amplified cryptate emission) technology, for procalcitonin, 419

Transcriptiomics, for *Mycobacterium tuberculosis,* 561

Transcription-mediated amplification assay, for trichomoniasis, 473

Trematodes, 487--488

Trichomoniasis, 473, 488--489

*Trichophyton,* MALDI-TOF mass spectrometry for, 576

*Trichuris trichiura,* 486

Trypanosomiasis

 African, 467--468

 American (Chagas disease), 476--477

Tube coagulase test, for blood cultures, 673

Tuberculosis. *See Mycobacterium tuberculosis.*

Typing and subtyping. *See* Strain typing.

U {#sec20}
=

Ulcerative colitis, 543

Urine

 MALDI-TOF mass spectrometry for, direct microorganism detection in, 601--602, 617--618

 tuberculosis biomarkers in, 559

V {#sec21}
=

Vancomycin resistance and susceptibility, *Enterococcus,* 601, 603, 622, 657

Variable number tandem repeats, for strain typing, 636

Vasopressin, in sepsis, 417, 420

Verigene *C difficile* Test, 530--531, 533--534

Verigene Gram-Negative Blood Culture Nucleic Acid Test, 663

Verigene Gram-Positive Blood Culture Nucleic Acid Test, 423, 426, 656--657, 662--663

Verigene RV+, for respiratory viruses, 446--448

*Vibrio,* 528, 535, 542, 548, 639

*Vibrio cholerae,* 546

VIDAS enzyme-linked fluorescent immunoassay, for procalcitonin, 419

Viral infections

 gastrointestinal, 528, 534--535, 544

 respiratory, **439--460**

Virulence Factors Database, 644

Virus neutralization assays, for gastroenteritis, 545

VITEK 2, for blood cultures, 664--665

Vitek AutoMicrobic system, 706, 708

VITEK MS. *See* bioMérieux VITEX MS.

*Vittaforma,* 489--490

VYOO assay, for sepsis, 424, 428

W {#sec22}
=

Walk-Away Specimen Processor, 571--572, 576--577, 708

Wampole Isolator, 652

Whole-genome sequencing, 632, 640--642

Workforce shortages, 645

Worms, intestinal, 487--488

*Wuchereria bancrofti,* 468, 479--480

X {#sec23}
=

Xpert *C difficile* assay, 530--532

Xpert *C difficile/*Epi assay, 530--532

Xpert MRSA/SA assay, 423--425, 663

Xpert MTV/RIF test, 556--558

xTAG Fungal ASR Luminex assay, 512, 514

xTAG Gastrointestinal Pathogen Panel, 486--487, 536--537, 721--722

xTAG Respiratory Virus Panel, 449--451

xTAG RVP *FAST* assays, 449--451

Y {#sec24}
=

Yeast Traffic Light PNA FISH assay, 512, 514

*Yersinia,* 535

*Yersinia enterocolitica,* 528, 535
